Centogene N.v. buy krebskrebs
Start price
27.07.20
/
50%
€11.90
Target price
04.11.21
€20.00
Performance (%)
-31.43%
End price
05.11.21
€8.16
Summary
This prediction ended on 05.11.21 with a price of €8.16. Massive losses of -31.43% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Centogene N.v. | - | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
Comments by krebskrebs for this prediction
In the thread Centogene N.v. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Centogene N.v.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten